Analysis Of Cardiovas Cular Medicine Marketing Strategy Of A Company

Pharmaceutical industry is called the eternal sunrise industry. According to statistics, from2003to2012nearly10years, the global pharmaceutical market sales to maintain an annual growth rate of about10%, much higher than the growth rate of the world economy.2012. China has become the world’s sixth-largest pharmaceutical market, is expected in2020China will become the world’s second largest pharmaceutical market after the United States, the market capacity will reach more than2000billion dollars. The global pharmaceutical market, and its central cerebral vascular drugs accounted for about21%. However, my cardiovascular drug market relative to the developed world, is still in its infancy. At present, China’s cardiovascular drugs has become a national second largest category of medicines, is the largest of a proprietary class of drugs. In all classes of cardiovascular drugs, medicine about39%market share. In the treatment of cardiovascular and cerebrovascular diseases, antibiotic drugs, compared with Western medicine does not have an absolute advantage, the effect is very significant. In contrast. Chinese medicine in the treatment of cardiovascular and cerebrovascular disease, but has a significant effect, therefore, patients are increasingly becoming the drug of choice.Z A pharmaceutical drug is independently developed a new class of drugs, since1989officially began in the domestic market.2006to2010for four consecutive years, and achieved sales of a single species in the national medicine first good results. Drug for the prevention of angina, coronary heart disease, myocardial ischemia, arrhythmia have a significant effect, it can be said is the treatment of cardiovascular and cerebrovascular diseases, drugs, strong brand, the top three. By2010. sales had reached610million yuan. However, with domestic and foreign enterprises continue to enter the growing number of brands, marketing tools close to homogeneity, the treatment of cardiovascular medicine, increasingly fierce competition in the industry, the price war has been launched in the industry. Additionally, with the Z drugs experienced a market development, through the period of rapid market growth, it is now the bottleneck into the sales period. Therefore, at this moment. A group how cardiovascular and cerebrovascular pharmaceutical market competition, through the open aggressive care, improved market campMarketing strategies, adjusting means of competition, the Z class of cardiovascular drugs this medicine again achieved strong sales of the brand new one leap, the Z-drugs maintain long-term stable growth, is the main purpose of this study and to solve major problem. Through the marketing of STP theory.4P+4C theory, and the theory of market competition and other related research and application of theories, trying to change the Z drug current market positioning, market segmentation and business marketing marketing strategies to be further enhanced into A Group’s competitiveness. Study sought through a new form of integrated marketing new drugs launched the second generation Z, product innovation; study also attempts through customer relationship management theory research is needed to accurately grasp customer needs and consumer buying behavior, improve customer satisfaction, so that customers more loyal; Finally, the study also applied course subdivision, target customers for accurate marketing.The authors suggest, with integrated marketing, should further increase the Z drugs brand culture propaganda, culture and the occupation of the market:implement diversified marketing, etc. to enhance the core competitiveness of Z drugs.